Renaissance Technologies - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 19 filers reported holding EVOKE PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q1 2022$14,000
-44.0%
28,200
-38.1%
0.00%
Q4 2021$25,000
-94.8%
45,535
-75.7%
0.00%
-100.0%
Q4 2020$483,000
+360.0%
187,276
+739.8%
0.00%
Q3 2020$105,000
+707.7%
22,300
+4.0%
0.00%
Q2 2019$13,000
-95.2%
21,442
-82.1%
0.00%
Q3 2016$271,000
+110.1%
120,000
+534.9%
0.00%
Q2 2016$129,000
+239.5%
18,900
+43.2%
0.00%
Q3 2015$38,000
-44.1%
13,200
+1.4%
0.00%
Q2 2015$68,00013,0240.00%
Other shareholders
EVOKE PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Wambolt & Associates, LLC 33,165$29,0000.02%
STATE OF MICHIGAN RETIREMENT SYSTEM 400,000$344,0000.00%
A.R.T. Advisors, LLC 36,954$32,0000.00%
NORTHERN TRUST CORP 33,997$29,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 199,678$171,0000.00%
CITIGROUP INC 500$00.00%
MORGAN STANLEY 1,450$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 36,700$32,0000.00%
BlackRock Inc. 54,940$47,0000.00%
View complete list of EVOKE PHARMA INC shareholders